Cargando…
Radiomics in esophageal and gastric cancer
Esophageal, esophago-gastric, and gastric cancers are major causes of cancer morbidity and cancer death. For patients with potentially resectable disease, multimodality treatment is recommended as it provides the best chance of survival. However, quality of life may be adversely affected by therapy,...
Autores principales: | Sah, Bert-Ram, Owczarczyk, Kasia, Siddique, Musib, Cook, Gary J. R., Goh, Vicky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934409/ https://www.ncbi.nlm.nih.gov/pubmed/30116873 http://dx.doi.org/10.1007/s00261-018-1724-8 |
Ejemplares similares
-
Challenges and Promises of PET Radiomics
por: Cook, Gary J.R., et al.
Publicado: (2018) -
Adaptive statistical iterative reconstruction (ASIR) affects CT radiomics quantification in primary colorectal cancer
por: Prezzi, Davide, et al.
Publicado: (2019) -
Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome
por: Yip, Connie, et al.
Publicado: (2015) -
Magnetic Resonance Imaging (MRI) of Intratumoral Voxel Heterogeneity as a Potential Response Biomarker: Assessment in a HER2+ Esophageal Adenocarcinoma Xenograft Following Trastuzumab and/or Cisplatin Therapy()()
por: Yip, Connie, et al.
Publicado: (2017) -
Does Measurement of First-Order and Heterogeneity Parameters Improve Response Assessment of Bone Metastases in Breast Cancer Compared to SUV(max) in [(18)F]fluoride and [(18)F]FDG PET?
por: Azad, Gurdip K., et al.
Publicado: (2018)